Actelion Pharmaceuticals US, Inc. et al v. Lannett Company, Inc.
Delaware District Court | |
Judge: | Gregory B Williams |
Case #: | 1:24-cv-01162 |
Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
Cause | 35:271 Patent Infringement |
Case Filed: | Oct 18, 2024 |
Terminated: | Jan 23, 2025 |
Last checked: Wednesday Apr 16, 2025 4:35 AM EDT |
Defendant
Lannett Company, Inc.
|
|
Plaintiff
Actelion Pharmaceuticals Ltd
|
Represented By
|
Plaintiff
Actelion Pharmaceuticals US, Inc.
|
Represented By
|
Plaintiff
Shinyaku Co., Ltd.
|
Represented By
|
Docket last updated: 4 hours ago |
Thursday, January 23, 2025 | ||
11 | 11
![]() Report to the Commissioner of Patents and Trademarks. (lnb) |
|
10 | 10
![]() CONSENT JUDGMENT. Signed by Judge Gregory B. Williams on 1/23/2025. (lnb) |
|
Wednesday, January 22, 2025 | ||
9 | 9
![]() PROPOSED CONSENT JUDGMENT AND INJUNCTION, by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.. (Balick, Steven) |
|
Tuesday, December 31, 2024 | ||
order
SO ORDERED
Tue 12/31 11:47 AM
SO ORDERED, re8 Unopposed MOTION for Extension of Time to File Answer filed by Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd., Actelion Pharmaceuticals US, Inc. Signed by Judge Gregory B. Williams on 12/31/24. (jaa) |
||
Tuesday, December 17, 2024 | ||
8 | 8
![]() Unopposed MOTION for Extension of Time to File Answer - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.. (Balick, Steven) |
|
Thursday, October 24, 2024 | ||
7 | 7
![]() WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.: For Lannett Company, Inc. waiver sent on 10/23/2024, answer due 12/23/2024. (Balick, Steven) |
|
Wednesday, October 23, 2024 | ||
utility
Case Assigned/Reassigned
Wed 10/23 1:06 PM
Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
||
Thursday, October 17, 2024 | ||
6 | 6
![]() Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shinyaku Co., Ltd.. (scs) |
|
5 | 5
![]() Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. (scs) |
|
4 | 4
![]() Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122; 9,284,280. (scs) |
|
3 | 3
![]() Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/08/2024. Date of Expiration of Patent: 06/25/2030. Thirty Month Stay Deadline: 3/9/2027. (scs) |
|
2 | 2
![]() Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
|
1 | 1
![]() COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Lannett Company, Inc. ( Filing fee $ 405, receipt number ADEDC-4526668.) - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd..(scs) |
|
Att: 1
![]() |
||
Att: 2
![]() |
||
Att: 3
![]() |
||
service
No Summons Issued
Fri 10/18 9:32 AM
No Summons Issued. (scs) |